NCT02300402View on ClinicalTrials.gov

Detection and Characterization of Residual Masses in Lymphomas

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Hodgkin LymphomaB-Cell Lymphoma
Trial Locations (1)

94010

Hopital Henri Mondor, Créteil

All Listed Sponsors
lead

The Lymphoma Academic Research Organisation

OTHER

NCT02300402 - Detection and Characterization of Residual Masses in Lymphomas | Biotech Hunter | Biotech Hunter